Amarin Corp PLC (AMRN)
0.8545
-0.03
(-2.90%)
USD |
NASDAQ |
May 10, 16:00
0.8545
0.00 (0.00%)
After-Hours: 18:08
Amarin Revenue (TTM): 277.46M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 277.46M |
| December 31, 2023 | 306.91M |
| September 30, 2023 | 322.44M |
| June 30, 2023 | 346.26M |
| March 31, 2023 | 360.54M |
| December 31, 2022 | 369.19M |
| September 30, 2022 | 423.44M |
| June 30, 2022 | 475.60M |
| March 31, 2022 | 535.65M |
| December 31, 2021 | 583.19M |
| September 30, 2021 | 605.95M |
| June 30, 2021 | 620.41M |
| March 31, 2021 | 601.24M |
| December 31, 2020 | 614.06M |
| September 30, 2020 | 590.09M |
| June 30, 2020 | 546.00M |
| March 31, 2020 | 511.47M |
| December 31, 2019 | 429.76M |
| September 30, 2019 | 363.81M |
| June 30, 2019 | 306.72M |
| March 31, 2019 | 258.57M |
| December 31, 2018 | 229.22M |
| September 30, 2018 | 205.75M |
| June 30, 2018 | 197.79M |
| March 31, 2018 | 190.39M |
| Date | Value |
|---|---|
| December 31, 2017 | 181.10M |
| September 30, 2017 | 165.93M |
| June 30, 2017 | 151.31M |
| March 31, 2017 | 139.18M |
| December 31, 2016 | 130.08M |
| September 30, 2016 | 118.02M |
| June 30, 2016 | 106.77M |
| March 31, 2016 | 91.37M |
| December 31, 2015 | 81.76M |
| September 30, 2015 | 71.60M |
| June 30, 2015 | 64.27M |
| March 31, 2015 | 59.17M |
| December 31, 2014 | 54.20M |
| September 30, 2014 | 47.83M |
| June 30, 2014 | 42.08M |
| March 31, 2014 | 34.98M |
| December 31, 2013 | 26.35M |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
277.46M
Minimum
Mar 2024
620.41M
Maximum
Jun 2021
459.51M
Average
452.68M
Median
Revenue (TTM) Benchmarks
| Trinity Biotech PLC | 56.83M |
| DBV Technologies SA | -- |
| Adaptimmune Therapeutics PLC | 60.28M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 0.4761M |